Composition and method of using eicosanoyl-5-hydroxytryptamide for treating neurodegenerative disorders
AssigneeVidya Herbs, Inc.
InventorKodimule Shyam Prasad
Life of this patent
Estimating the term…
Abstract
The invention provides a composition comprising one or more hydroxytryptamides and method of its use in the treatment of neurodegenerative disorders. The invention includes embodiments wherein the composition comprises caffeine and chlorogenic acids. The composition finds use in the treatment of Alzheimer's disease and Parkinson's disease, including providing neuroprotection against the advancement of the symptoms of these disorders.
Claims22
A method of treating a neurodegenerative disorder, comprising administering to a patient in need thereof an effective amount of a composition comprising about 10% w/w eicosanoyl-5-hydroxytryptamide, wherein administering said composition treats said neurodegenerative disorder and wherein said composition further comprises about 0.40% w/w octadecanoic hydroxytryptamide, about 0.30% w/w heneicosanoic hydroxytryptamide, about 4.60% w/w docosanoic hydroxytryptamide, about 0.40% w/w tricosanoic hydroxytryptamide, about 0.90% w/w tetracosanoic hydroxytryptamide, and about 0.10% pentacosanoic hydroxytryptamide.
A composition for treating a neurodegenerative disorder, comprising about 10% w/w eicosanoyl-5-hydroxytryptamide wherein said composition further comprises about 0.40% w/w octadecanoic hydroxytryptamide, about 0.30% w/w heneicosanoic hydroxytryptamide, about 4.60% w/w docosanoic hydroxytryptamide, about 0.40% w/w tricosanoic hydroxytryptamide, about 0.90% w/w tetracosanoic hydroxytryptamide, and about 0.10% pentacosanoic hydroxytryptamide.
Dependencies are inferred from the claim text.